BEVESPI AEROSPHERE (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the BEVESPI AEROSPHERE drug offered from AstraZeneca Pharmaceuticals LP. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Glycopyrrolate and formoterol fumarate |
| SUBSTANCE NAME: | GLYCOPYRROLATE; FORMOTEROL FUMARATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | AEROSOL, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-10-03 |
| END MARKETING DATE: | 0000-00-00 |
BEVESPI AEROSPHERE HUMAN PRESCRIPTION DRUG Details:
| Item Description | BEVESPI AEROSPHERE from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 9; 4.8(ug/1; ug/1) |
| START MARKETING DATE: | 2016-10-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-4600_8acbfd94-8b5a-415b-9b84-66baad273763 |
| PRODUCT NDC: | 0310-4600 |
| APPLICATION NUMBER: | NDA208294 |
Other GLYCOPYRROLATE; FORMOTEROL FUMARATE Pharmaceutical Manufacturers / Labelers:
